Similar results have been reported in carcinogen-induced urothelial tumors, where initiation of tumors in CD24-/- mice was significantly delayed, but tumor incidence was not significantly different between wild-type and CD24-/- mice 28 weeks after treatment with carcinogen [52]. Here, CD24 is linked to neoplasm.